Oscars’ inclusion standards for kidney trials

IF 46.7 1区医学 Q1 UROLOGY & NEPHROLOGY

Nature Reviews Nephrology Pub Date : 2026-07-15 DOI:10.1038/s41581-026-01106-9

Rathika Krishnasamy

引用次数: 0

Abstract

Despite growing awareness of inequities in kidney research, high-impact trials remain predominantly led by men from high-income countries, and important disparities persist in the recruitment of women and populations disproportionately affected by chronic kidney disease. It is time to move beyond acknowledgement of such disparities and commit to inclusion standards that systemically transform kidney research.

查看原文本刊更多论文

奥斯卡对肾脏试验的纳入标准。

尽管人们越来越意识到肾脏研究中的不平等，但高影响试验仍然主要由高收入国家的男性领导，在招募女性和慢性肾病患者方面仍然存在重大差异。现在是时候超越对这种差异的承认，并致力于系统地改变肾脏研究的纳入标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Nephrology 医学-泌尿学与肾脏学

CiteScore

39.00

自引率

1.20%

发文量

127

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Nephrology aims to be the premier source of reviews and commentaries for the scientific communities it serves. It strives to publish authoritative, accessible articles. Articles are enhanced with clearly understandable figures, tables, and other display items. Nature Reviews Nephrology publishes Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements. The content is relevant to nephrologists and basic science researchers. The broad scope of the journal ensures that the work reaches the widest possible audience.